13866 Federal Register / Vol. 80, No. 51 / Tuesday, March 17, 2015 / Notices 

The Education and Community 

Involvement Branch (ECIB) designed the 

program to accomplish the following 

goals, which align with elements of both 

the NIH and NHGRI missions: 

• Expand NIH and NHGRI’s 

professional network to reach out to 

diverse communities, and to create new 

partnership opportunities. 

• Prepare the next generation of 

genomics professionals for an era of 

genomic medicine. 

• Train and diversify the pipeline of 

genome professionals in alignment with 

the NIH and US Department of Health 

and Human Services diversity efforts. 

The ECIB has systematically collected 

feedback annually after the program 

from participants since inception of the 

Short Course in 2003, and then used the 

data to tweak the program, but it has not 

conducted a long-term, cumulative and 

substantive outcome evaluation. NHGRI 

and the ECIB propose to conduct such 

an outcome evaluation, focusing on 

three main objectives: 

(1) To understand the degree of 

genetic and genomic curriculum 

integration by faculty participants; 

(2) To explore the barriers and 

supports faculty experience and changes 

when integrating curriculum; and 

(3) To investigate the influence of the 

program on the participants’ career 

path. 

Survey findings will provide valuable 

information about the various methods 

and pathways instructors use to 

disseminate new knowledge (and the 

associated timelines), the barriers and 

supports experienced by faculty as they 

integrate new knowledge into their 

teaching, and insights about additional 

avenues of support that NHGRI could 

provide teaching faculty from the types 

of institutions identified. Key indicators 

will also provide evidence about the 

degree to which the Short Course is 

meeting its goals. Collectively, the 

outcome evaluation will inform future 

program design and budget allocations. 

OMB approval is requested for 2 

years. There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

155. 

ESTIMATED ANNUALIZED BURDEN HOURS

Form name Type of 

respondents 

Number of 

respondents 

Number of 

responses 

per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

annual 

burden 

hours 

Short Course Survey—Students ..................................... Students ............................. 110 1 30/60 55 

Short Course Survey—Faculty ........................................ Faculty ............................... 200 1 30/60 100 

Totals ........................................................................ ............................................ 310 .................... .................... 155 

Dated: March 11, 2015. 

Gloria Butler, 

NHGRI Project Clearance Liaison, National 

Institutes of Health. 

[FR Doc. 2015–06086 Filed 3–16–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2015–N–0001] 

Vaccines and Related Biological 

Products Advisory Committee; Notice 

of Meeting 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

This notice announces a forthcoming 

meeting of a public advisory committee 

of the Food and Drug Administration 

(FDA). The meeting will be open to the 

public. 

Name of Committee: Vaccines and 

Related Biological Products Advisory 

Committee. 

General Function of the Committee: 

To provide advice and 

recommendations to the Agency on 

FDA’s regulatory issues. 

Date and Time: The meeting will be 

held on May 12, 2015, from 8:30 a.m. to 

5 p.m. 

Location: FDA White Oak Campus, 

10903 New Hampshire Ave., Building 

31 Conference Center, the Great Room 

(Rm. 1503), Silver Spring, MD 20993. 

Answers to commonly asked questions 

including information regarding special 

accommodations due to a disability, 

visitor parking, and transportation may 

be accessed at: http://www.fda.gov/

AdvisoryCommittees/AboutAdvisory

Committees/ucm408555.htm. For those 

unable to attend in person, the meeting 

will also be Web cast and will be 

available at the following link: https:// 

collaboration.fda.gov/vrbpac0515/. 

Contact Person: Sujata Vijh, Center for 

Biologics Evaluation and Research, 

Food and Drug Administration, 10903 

New Hampshire Ave., Bldg. 71, Rm. 

6128, Silver Spring, MD 209930–0002, 

240–402–7107; or Denise Royster, 

Center for Biologics Evaluation and 

Research, Food and Drug 

Administration, 10903 New Hampshire 

Ave., Bldg. 71, Rm. 6134, Silver Spring, 

MD 209930–0002, 240–402–8158; or 

FDA Advisory Committee Information 

Line, 1–800–741–8138 (301–443–0572 

in the Washington, DC area). A notice in 

the Federal Register about last minute 

modifications that impact a previously 

announced advisory committee meeting 

cannot always be published quickly 

enough to provide timely notice. 

Therefore, you should always check the 

Agency’s Web site at http://

www.fda.gov/AdvisoryCommittees/

default.htm and scroll down to the 

appropriate advisory committee meeting 

link, or call the advisory committee 

information line to learn about possible 

modifications before coming to the 

meeting. 

Agenda: On May 12, 2015, from 8:30 

a.m. to 5 p.m., the committee will meet 

in open session to discuss the 

development and licensure of Ebola 

vaccines. 

FDA intends to make background 

material available to the public no later 

than 2 business days before the meeting. 

If FDA is unable to post the background 

material on its Web site prior to the 

meeting, the background material will 

be made publicly available at the 

location of the advisory committee 

meeting, and the background material 

will be posted on FDA’s Web site after 

the meeting. Background material is 

available at http://www.fda.gov/

AdvisoryCommittees/Calendar/

default.htm. Scroll down to the 

appropriate advisory committee meeting 

link. 

Procedure: Interested persons may 

present data, information, or views, 

orally or in writing, on issues pending 

before the committee. Written 

submissions may be made to the contact 

person on or before May 5, 2015. Oral 

presentations from the public will be 

scheduled between 1:15 p.m. and 2:15 

p.m. Those individuals interested in 

making formal oral presentations should 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 80, No. 51 / Tuesday, March 17, 2015 / Notices 13867 

notify the contact person and submit a 

brief statement of the general nature of 

the evidence or arguments they wish to 

present, the names and addresses of 

proposed participants, and an 

indication of the approximate time 

requested to make their presentation on 

or before April 27, 2015. Time allotted 

for each presentation may be limited. If 

the number of registrants requesting to 

speak is greater than can be reasonably 

accommodated during the scheduled 

open public hearing session, FDA may 

conduct a lottery to determine the 

speakers for the scheduled open public 

hearing session. The contact person will 

notify interested persons regarding their 

request to speak by April 28, 2015. 

Persons attending FDA’s advisory 

committee meetings are advised that the 

Agency is not responsible for providing 

access to electrical outlets. 

FDA welcomes the attendance of the 

public at its advisory committee 

meetings and will make every effort to 

accommodate persons with physical 

disabilities or special needs. If you 

require special accommodations due to 

a disability, please contact Sujata Vijh 

(see Contact Person) at least 7 days in 

advance of the meeting. 

FDA is committed to the orderly 

conduct of its advisory committee 

meetings. Please visit our Web site at 

http://www.fda.gov/Advisory

Committees/AboutAdvisoryCommittees/

ucm111462.htm for procedures on 

public conduct during advisory 

committee meetings. 

Notice of this meeting is given under 

the Federal Advisory Committee Act (5 

U.S.C. app. 2). 

Dated: March 13, 2015. 

Leslie Kux, 

Associate Commissioner for Policy. 

[FR Doc. 2015–06116 Filed 3–16–15; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVCES 

Substance Abuse and Mental Health 

Services Administration 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

In compliance with Section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995 concerning 

opportunity for public comment on 

proposed collections of information, the 

Substance Abuse and Mental Health 

Services Administration (SAMHSA) 

will publish periodic summaries of 

proposed projects. To request more 

information on the proposed project or 

to obtain a copy of the information 

collection plans, call the SAMHSA 

Reports Clearance Officer on (240) 276– 

1243. 

Comments are invited on: (a) Whether 

the proposed collection of information 

are necessary for the proper 

performance of the functions of the 

agency, including whether the 

information shall have practical utility; 

(b) the accuracy of the agency’s estimate 

of the burden of the proposed collection 

of information; (c) ways to enhance the 

quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Proposed Project Behavioral Health 

Information Technologies Survey— 

NEW 

The Substance Abuse and Mental 

Health Services Administration 

(SAMHSA) Center for Substance Abuse 

Treatment (CSAT) and Center for 

Behavioral Health Statistics and Quality 

(CBHSQ) are proposing a survey to 

assess health information technology 

(HIT) adoption among SAMHSA 

grantees. As part of its Strategic 

Initiative to advance the use of health 

information technologies to support 

integrated behavioral health care, 

SAMHSA has been working to develop 

a survey instrument that will examine 

the status of and plans for HIT adoption 

by behavioral health service providers 

who are implementing SAMHSA grant 

programs. The selected programs are 

funded by the by the Center for Mental 

Health Services (CMHS), the Center for 

Substance Abuse Prevention (CSAP), 

and (CSAT). 

This project seeks to acquire baseline 

data necessary to inform the Agency’s 

strategic initiative that focuses on 

fostering the adoption of HIT in 

community behavioral health services. 

The survey of SAMHSA grantees 

regarding their access to and use of 

health information technology will 

provide valuable information that will 

inform the behavioral HIT literature. 

Approval of this data collection by the 

Office of Management and Budget 

(OMB) will allow SAMHSA to identify 

the current status of HIT adoption and 

use among a diverse group of grantees. 

Data from the survey will allow 

SAMHSA to enhance the HIT-related 

programmatic activities among its 

grantees by providing data on how HIT 

facilitates the implementation of 

different types of SAMHSA grants, 

thereby fostering the appropriate 

adoption of HIT within SAMSHAfunded programs. 

The survey will collect data once, 

providing a snapshot view of the current 

state of HIT adoption. The proposed 

participant pool is comprised of 

SAMHSA grantee program leadership 

who are willing to provide the 

assistance needed to ensure a high rate 

of response. Awardees from nine 

different SAMHSA programs drawn 

from CMHS, CSAT, and CSAP comprise 

the pool of survey participants. 

The survey mode for data collection 

will be web-based with embedded skip 

logic for respondents to avoid questions 

that are not applicable to them. The 

minimum amount of time for a 

respondent to complete the survey is 20 

minutes, with respondents who do not 

skip items taking a maximum of 30 

minutes for completion. The total 

estimated respondent burden is 149.6 

hours. 

The following table summarizes the 

estimated response burden. 

Type of grantee or respondent Number of 

respondents 

Number of 

responses 

annually per 

respondent 

Total 

responses 

Average hours 

per response 

Total burden 

hours 

Screening, Brief Intervention, and Referral to Treatment 

(SBIRT) ............................................................................. 18 1 18 .4 7.2 

Targeted Capacity Expansion-Targeted Assisted Care ...... 17 1 17 .4 6.8 

Offender Re-entry Program ................................................. 13 1 13 .4 5.2 

Primary Behavioral Health Care Integration (PBHCI) ......... 89 1 89 .4 35.6 

National Child Traumatic Stress Initiative (NCTSI) ............. 56 1 56 .4 22.4 

Suicide Lifeline Crisis Center Follow-up .............................. 12 1 12 .4 4.8 

mstockstill on DSK4VPTVN1PROD with NOTICES